Cherry Lim
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Burkholderia infections and melioidosis 4
-
- Antibiotic Use and Resistance 6
- Co-authors
- Direk Limmathurotsakul (13 shared papers)Nicholas Day (10 shared papers)Sharon J. Peacock (5 shared papers)Vanaporn Wuthiekanun (4 shared papers)Ben S. Cooper (11 shared papers)Maliwan Hongsuwan (2 shared papers)Soawapak Hinjoy (1 shared paper)Emi Takahashi (1 shared paper)
- Journals
- Clinical Microbiology and Infection (3 papers)Journal of Clinical Microbiology (2 papers)PLoS ONE (2 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)Epidemiology and Infection (1 paper)
- Partner nations
- ThailandUnited KingdomAustralia
In The Last Decade
Cherry Lim
22 papers receiving 665 citations
Peers
Comparison fields: 5 of 93
- Applied Microbiology and Biotechnology 130
- Molecular Medicine 119
- Parasitology 150
- Clinical Biochemistry 43
- Critical Care and Intensive Care Medicine 24
Countries citing papers authored by Cherry Lim
This map shows the geographic impact of Cherry Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherry Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherry Lim more than expected).
Fields of papers citing papers by Cherry Lim
This network shows the impact of papers produced by Cherry Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherry Lim. The network helps show where Cherry Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Cherry Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 224 | |
| 2 | 2015 | 60 | |
| 3 | 2015 | 44 | |
| 4 | 2020 | 41 | |
| 5 | 2016 | 37 | |
| 6 | 2013 | 37 | |
| 7 | 2021 | 34 | |
| 8 | 2023 | 30 | |
| 9 | 2016 | 28 | |
| 10 | 2023 | 24 | |
| 11 | 2020 | 22 | |
| 12 | 2017 | 21 | |
| 13 | 2015 | 19 | |
| 14 | Factors associated with adherence to low-tidal volume strategy for acute lung injury and acute respiratory distress syndrome and their impacts on outcomes: an observational study and propensity analysis. | 2014 | 14 |
| 15 | 2021 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2022 | 9 | |
| 18 | 2016 | 6 | |
| 19 | 2022 | 4 | |
| 20 | 2013 | 4 |
About Cherry Lim
Cherry Lim is a scholar working on Epidemiology, Applied Microbiology and Biotechnology, Public Health, Environmental and Occupational Health, Parasitology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 685 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (6 papers), Burkholderia infections and melioidosis (4 papers), Vector-borne infectious diseases (3 papers), Antibiotic Resistance in Bacteria (3 papers), Infection Control and Ventilation (2 papers), Mosquito-borne diseases and control (2 papers), Global Maternal and Child Health (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (130 citations), Molecular Medicine (119 citations), Parasitology (150 citations), Clinical Biochemistry (43 citations) and Critical Care and Intensive Care Medicine (24 citations). Cherry Lim has collaborated with scholars based in Thailand, United Kingdom and Australia. Frequent co-authors include Direk Limmathurotsakul, Nicholas Day, Sharon J. Peacock, Vanaporn Wuthiekanun, Ben S. Cooper, Maliwan Hongsuwan, Soawapak Hinjoy, Emi Takahashi, Visanu Thamlikitkul and Yin Mo. Their work appears in journals such as Clinical Microbiology and Infection, Journal of Clinical Microbiology, PLoS ONE, JAIDS Journal of Acquired Immune Deficiency Syndromes and Epidemiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.